{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:40:12Z","timestamp":1784302812810,"version":"3.55.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00316"],"award-info":[{"award-number":["PI20\/00316"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI23\/00224"],"award-info":[{"award-number":["PI23\/00224"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD21\/0002\/0034"],"award-info":[{"award-number":["RD21\/0002\/0034"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD24\/0007\/0029"],"award-info":[{"award-number":["RD24\/0007\/0029"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00847"],"award-info":[{"award-number":["PI20\/00847"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI23\/01226"],"award-info":[{"award-number":["PI23\/01226"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD21\/0002\/0027"],"award-info":[{"award-number":["RD21\/0002\/0027"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD24\/0007\/0006"],"award-info":[{"award-number":["RD24\/0007\/0006"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["P2022\/BMD-7274"],"award-info":[{"award-number":["P2022\/BMD-7274"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-026-06162-9","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T03:53:29Z","timestamp":1773719609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Monocytes from inflammatory arthritis patients accumulate methotrexate and their transcriptome predicts methotrexate clinical response"],"prefix":"10.1007","volume":"83","author":[{"given":"Israel","family":"R\u00edos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Teresa","family":"Schiaffino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baltasar","family":"L\u00f3pez-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Triguero-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marry","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Torres-Torresano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard A.","family":"Struys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Abad-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santos","family":"Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Garcia-Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Castrej\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidoro","family":"Gonz\u00e1lez-\u00c1lvaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2943-9757","authenticated-orcid":false,"given":"Amaya","family":"Puig-Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"issue":"1","key":"6162_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/ard-2022-223356","volume":"82","author":"JS Smolen","year":"2023","unstructured":"Smolen JS, Landewe RBM, Bergstra SA, Kerschbaumer A, Sepriano A, Aletaha D et al (2023) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis 82(1):3\u201318","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"6162_CR2","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/ard-2024-225531","volume":"83","author":"L Gossec","year":"2024","unstructured":"Gossec L, Kerschbaumer A, Ferreira RJO, Aletaha D, Baraliakos X, Bertheussen H et al (2024) EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Ann Rheum Dis 83(6):706\u2013719","journal-title":"Ann Rheum Dis"},{"issue":"71 Suppl 1","key":"6162_CR3","first-page":"S9","volume":"2013","author":"T Pincus","year":"2013","unstructured":"Pincus T, Gibson KA, Castrejon I (2013) Update on methotrexate as the anchor drug for rheumatoid arthritis. Bull Hosp Jt Dis 2013(71 Suppl 1):S9-19","journal-title":"Bull Hosp Jt Dis"},{"issue":"12","key":"6162_CR4","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrrheum.2016.175","volume":"12","author":"PM Brown","year":"2016","unstructured":"Brown PM, Pratt AG, Isaacs JD (2016) Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers. Nat Rev Rheumatol 12(12):731\u2013742","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"6162_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1046\/j.1365-2125.1998.t01-1-00790.x","volume":"46","author":"C Godfrey","year":"1998","unstructured":"Godfrey C, Sweeney K, Miller K, Hamilton R, Kremer J (1998) The population pharmacokinetics of long-term methotrexate in rheumatoid arthritis. Br J Clin Pharmacol 46(4):369\u2013376","journal-title":"Br J Clin Pharmacol"},{"key":"6162_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev-nutr-072610-145133","volume":"31","author":"R Zhao","year":"2011","unstructured":"Zhao R, Diop-Bove N, Visentin M, Goldman ID (2011) Mechanisms of membrane transport of folates into cells and across epithelia. Annu Rev Nutr 31:177\u2013201","journal-title":"Annu Rev Nutr"},{"key":"6162_CR7","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0613345","author":"R Samaniego","year":"2014","unstructured":"Samaniego R, Palacios BS, Domiguez-Soto A, Vidal C, Salas A, Matsuyama T et al (2014) Macrophage uptake and accumulation of folates are polarization-dependent in vitro and in vivo and are regulated by activin A. J Leukoc Biol. https:\/\/doi.org\/10.1189\/jlb.0613345","journal-title":"J Leukoc Biol"},{"issue":"1","key":"6162_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/art.24219","volume":"60","author":"JW van der Heijden","year":"2009","unstructured":"van der Heijden JW, Oerlemans R, Dijkmans BA, Qi H, van der Laken CJ, Lems WF et al (2009) Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients. Arthritis Rheum 60(1):12\u201321","journal-title":"Arthritis Rheum"},{"issue":"1","key":"6162_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13046-019-1123-1","volume":"38","author":"B Frigerio","year":"2019","unstructured":"Frigerio B, Bizzoni C, Jansen G, Leamon CP, Peters GJ, Low PS et al (2019) Folate receptors and transporters: biological role and diagnostic\/therapeutic targets in cancer and other diseases. J Exp Clin Cancer Res 38(1):125","journal-title":"J Exp Clin Cancer Res"},{"key":"6162_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.drup.2016.06.004","volume":"28","author":"S Raz","year":"2016","unstructured":"Raz S, Stark M, Assaraf YG (2016) Folylpoly-gamma-glutamate synthetase: a key determinant of folate homeostasis and antifolate resistance in cancer. Drug Resist Updat 28:43\u201364","journal-title":"Drug Resist Updat"},{"issue":"2","key":"6162_CR11","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1136\/annrheumdis-2013-203725","volume":"74","author":"MC de Rotte","year":"2015","unstructured":"de Rotte MC, den Boer E, de Jong PH, Pluijm SM, Calasan MB, Weel AE et al (2015) Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in patients with rheumatoid arthritis. Ann Rheum Dis 74(2):408\u2013414","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6162_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/bcp.15579","volume":"89","author":"MM van de Meeberg","year":"2023","unstructured":"van de Meeberg MM, Hebing RCF, Nurmohamed MT, Fidder HH, Heymans MW, Bouma G et al (2023) A meta-analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis. Br J Clin Pharmacol 89(1):61\u201379","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"6162_CR13","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1136\/ard-2022-223398","volume":"82","author":"RC Hebing","year":"2023","unstructured":"Hebing RC, Lin M, Bulatovic Calasan M, Muller IB, Mahmoud S, Heil S et al (2023) Pharmacokinetics of oral and subcutaneous methotrexate in red and white blood cells in patients with early rheumatoid arthritis: the methotrexate monitoring trial. Ann Rheum Dis 82(4):460\u2013467","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"6162_CR14","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/path.4466","volume":"235","author":"B Soler Palacios","year":"2015","unstructured":"Soler Palacios B, Estrada-Capetillo L, Izquierdo E, Criado G, Nieto C, Municio C et al (2015) Macrophages from the synovium of active rheumatoid arthritis exhibit an activin A-dependent pro-inflammatory profile. J Pathol 235(3):515\u2013526","journal-title":"J Pathol"},{"issue":"6","key":"6162_CR15","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1136\/ard.2004.029751","volume":"64","author":"JJ Haringman","year":"2005","unstructured":"Haringman JJ, Gerlag DM, Zwinderman AH, Smeets TJ, Kraan MC, Baeten D et al (2005) Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann Rheum Dis 64(6):834\u2013838","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"6162_CR16","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/s41591-020-0939-8","volume":"26","author":"S Alivernini","year":"2020","unstructured":"Alivernini S, MacDonald L, Elmesmari A, Finlay S, Tolusso B, Gigante MR et al (2020) Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. Nat Med 26(8):1295\u20131306","journal-title":"Nat Med"},{"issue":"12","key":"6162_CR17","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1136\/annrheumdis-2015-208736","volume":"75","author":"C Municio","year":"2016","unstructured":"Municio C, Soler Palacios B, Estrada-Capetillo L, Benguria A, Dopazo A, Garcia-Lorenzo E et al (2016) Methotrexate selectively targets human proinflammatory macrophages through a thymidylate synthase\/p53 axis. Ann Rheum Dis 75(12):2157\u20132165","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"6162_CR18","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1136\/annrheumdis-2017-212537","volume":"77","author":"C Municio","year":"2018","unstructured":"Municio C, Dominguez-Soto A, Fuentelsaz-Romero S, Lamana A, Montes N, Cuevas VD et al (2018) Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism. Ann Rheum Dis 77(5):752\u2013759","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"6162_CR19","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1093\/rheumatology\/keac551","volume":"62","author":"MD Russell","year":"2023","unstructured":"Russell MD, Dey M, Flint J, Davie P, Allen A, Crossley A et al (2023) British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford) 62(4):e48\u2013e88","journal-title":"Rheumatology (Oxford)"},{"key":"6162_CR20","doi-asserted-by":"publisher","first-page":"116882","DOI":"10.1016\/j.jpba.2025.116882","volume":"262","author":"J Sundaresan","year":"2025","unstructured":"Sundaresan J, Lin M, Jansen G, Hebing RCF, Bulatovic-Calasan M, de Jonge R et al (2025) Unique methotrexate polyglutamates distributions in peripheral blood mononuclear cells of rheumatoid arthritis patients: development and validation of a UPLC-MS\/MS method. J Pharm Biomed Anal 262:116882","journal-title":"J Pharm Biomed Anal"},{"issue":"5","key":"6162_CR21","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s00216-012-6581-7","volume":"405","author":"E den Boer","year":"2013","unstructured":"den Boer E, Meesters RJ, van Zelst BD, Luider TM, Hazes JM, Heil SG et al (2013) Measuring methotrexate polyglutamates in red blood cells: a new LC-MS\/MS-based method. Anal Bioanal Chem 405(5):1673\u20131681","journal-title":"Anal Bioanal Chem"},{"issue":"5","key":"6162_CR22","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/FTD.0000000000000638","volume":"41","author":"IB Muller","year":"2019","unstructured":"Muller IB, Lin M, Struys EA, Heydari P, Hebing RCF, Nurmohamed MT et al (2019) Development and validation of a sensitive UHPLC-MS\/MS-based method for the analysis of folylpolyglutamate synthetase enzymatic activity in peripheral blood mononuclear cells: application in rheumatoid arthritis and leukemia patients. Ther Drug Monit 41(5):598\u2013606","journal-title":"Ther Drug Monit"},{"issue":"43","key":"6162_CR23","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102(43):15545\u201315550","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"6162_CR24","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1136\/annrheumdis-2019-215446","volume":"78","author":"J Bluett","year":"2019","unstructured":"Bluett J, Riba-Garcia I, Verstappen SMM, Wendling T, Ogungbenro K, Unwin RD et al (2019) Development and validation of a methotrexate adherence assay. Ann Rheum Dis 78(9):1192\u20131197","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"6162_CR25","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1084\/jem.20170355","volume":"214","author":"AA Patel","year":"2017","unstructured":"Patel AA, Zhang Y, Fullerton JN, Boelen L, Rongvaux A, Maini AA et al (2017) The fate and lifespan of human monocyte subsets in steady state and systemic inflammation. J Exp Med 214(7):1913\u20131923","journal-title":"J Exp Med"},{"issue":"3","key":"6162_CR26","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1172\/JCI111761","volume":"75","author":"S Koizumi","year":"1985","unstructured":"Koizumi S, Curt GA, Fine RL, Griffin JD, Chabner BA (1985) Formation of methotrexate polyglutamates in purified myeloid precursor cells from normal human bone marrow. J Clin Invest 75(3):1008\u20131014","journal-title":"J Clin Invest"},{"key":"6162_CR27","doi-asserted-by":"publisher","first-page":"776879","DOI":"10.3389\/fimmu.2021.776879","volume":"12","author":"S Fuentelsaz-Romero","year":"2021","unstructured":"Fuentelsaz-Romero S, Barrio-Alonso C, Garcia Campos R, Torres Torresano M, Muller IB, Triguero-Martinez A et al (2021) The macrophage reprogramming ability of antifolates reveals soluble CD14 as a potential biomarker for methotrexate response in rheumatoid arthritis. Front Immunol 12:776879","journal-title":"Front Immunol"},{"issue":"2","key":"6162_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/toxsci\/kfq007","volume":"114","author":"L Sparfel","year":"2010","unstructured":"Sparfel L, Pinel-Marie ML, Boize M, Koscielny S, Desmots S, Pery A et al (2010) Transcriptional signature of human macrophages exposed to the environmental contaminant benzo(a)pyrene. Toxicol Sci 114(2):247\u2013259","journal-title":"Toxicol Sci"},{"issue":"27","key":"6162_CR29","doi-asserted-by":"publisher","first-page":"15837","DOI":"10.1073\/pnas.2006949117","volume":"117","author":"DJ Kim","year":"2020","unstructured":"Kim DJ, Venkataraman A, Jain PC, Wiesler EP, DeBlasio M, Klein J et al (2020) Vitamin B12 and folic acid alleviate symptoms of nutritional deficiency by antagonizing aryl hydrocarbon receptor. Proc Natl Acad Sci U S A 117(27):15837\u201315845","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"6162_CR30","first-page":"445","volume":"37","author":"L Cheng","year":"2019","unstructured":"Cheng L, Qian L, Xu ZZ, Tan Y, Luo CY (2019) Aromatic hydrocarbon receptor provides a link between smoking and rheumatoid arthritis in peripheral blood mononuclear cells. Clin Exp Rheumatol 37(3):445\u2013449","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"6162_CR31","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41577-019-0125-8","volume":"19","author":"V Rothhammer","year":"2019","unstructured":"Rothhammer V, Quintana FJ (2019) The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease. Nat Rev Immunol 19(3):184\u2013197","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"6162_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/cmi.2011.59","volume":"9","author":"N Shembade","year":"2012","unstructured":"Shembade N, Harhaj EW (2012) Regulation of NF-kappaB signaling by the A20 deubiquitinase. Cell Mol Immunol 9(2):123\u2013130","journal-title":"Cell Mol Immunol"},{"issue":"11","key":"6162_CR33","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nri3313","volume":"12","author":"A Ma","year":"2012","unstructured":"Ma A, Malynn BA (2012) A20: linking a complex regulator of ubiquitylation to immunity and human disease. Nat Rev Immunol 12(11):774\u2013785","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"6162_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0167-5699(93)90212-4","volume":"14","author":"HW Ziegler-Heitbrock","year":"1993","unstructured":"Ziegler-Heitbrock HW, Ulevitch RJ (1993) CD14: cell surface receptor and differentiation marker. Immunol Today 14(3):121\u2013125","journal-title":"Immunol Today"},{"issue":"17","key":"6162_CR35","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1182\/blood-2013-02-484188","volume":"123","author":"C Schmidl","year":"2014","unstructured":"Schmidl C, Renner K, Peter K, Eder R, Lassmann T, Balwierz PJ et al (2014) Transcription and enhancer profiling in human monocyte subsets. Blood 123(17):e90\u2013e99","journal-title":"Blood"},{"issue":"5","key":"6162_CR36","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1182\/blood-2010-12-326355","volume":"118","author":"KL Wong","year":"2011","unstructured":"Wong KL, Tai JJ, Wong WC, Han H, Sem X, Yeap WH et al (2011) Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 118(5):e16-31","journal-title":"Blood"},{"issue":"4","key":"6162_CR37","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.4049\/jimmunol.1700148","volume":"199","author":"TU Metcalf","year":"2017","unstructured":"Metcalf TU, Wilkinson PA, Cameron MJ, Ghneim K, Chiang C, Wertheimer AM et al (2017) Human monocyte subsets are transcriptionally and functionally altered in aging in response to pattern recognition receptor agonists. J Immunol 199(4):1405\u20131417","journal-title":"J Immunol"},{"issue":"8","key":"6162_CR38","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.immuni.2021.07.007","volume":"54","author":"K Mulder","year":"2021","unstructured":"Mulder K, Patel AA, Kong WT, Piot C, Halitzki E, Dunsmore G et al (2021) Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease. Immunity 54(8):1883\u2013900 (e5)","journal-title":"Immunity"},{"issue":"2","key":"6162_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.immuni.2017.07.017","volume":"47","author":"K Kang","year":"2017","unstructured":"Kang K, Park SH, Chen J, Qiao Y, Giannopoulou E, Berg K et al (2017) Interferon-gamma represses M2 gene expression in human macrophages by disassembling enhancers bound by the transcription factor MAF. Immunity 47(2):235\u201350 (e4)","journal-title":"Immunity"},{"issue":"6","key":"6162_CR40","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.4049\/jimmunol.174.6.3484","volume":"174","author":"S Cao","year":"2005","unstructured":"Cao S, Liu J, Song L, Ma X (2005) The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages. J Immunol 174(6):3484\u20133492","journal-title":"J Immunol"},{"issue":"9","key":"6162_CR41","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/ni.1912","volume":"11","author":"L Apetoh","year":"2010","unstructured":"Apetoh L, Quintana FJ, Pot C, Joller N, Xiao S, Kumar D et al (2010) The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat Immunol 11(9):854\u2013861","journal-title":"Nat Immunol"},{"issue":"3","key":"6162_CR42","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1182\/blood-2009-07-235028","volume":"115","author":"MA Ingersoll","year":"2010","unstructured":"Ingersoll MA, Spanbroek R, Lottaz C, Gautier EL, Frankenberger M, Hoffmann R et al (2010) Comparison of gene expression profiles between human and mouse monocyte subsets. Blood 115(3):e10\u2013e19","journal-title":"Blood"},{"key":"6162_CR43","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/1471-2164-10-403","volume":"10","author":"P Ancuta","year":"2009","unstructured":"Ancuta P, Liu KY, Misra V, Wacleche VS, Gosselin A, Zhou X et al (2009) Transcriptional profiling reveals developmental relationship and distinct biological functions of CD16+ and CD16- monocyte subsets. BMC Genomics 10:403","journal-title":"BMC Genomics"},{"issue":"2","key":"6162_CR44","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/annrheumdis-2017-211649","volume":"77","author":"B Smiljanovic","year":"2018","unstructured":"Smiljanovic B, Radzikowska A, Kuca-Warnawin E, Kurowska W, Grun JR, Stuhlmuller B et al (2018) Monocyte alterations in rheumatoid arthritis are dominated by preterm release from bone marrow and prominent triggering in the joint. Ann Rheum Dis 77(2):300\u2013308","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6162_CR45","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/BF00296254","volume":"19","author":"H Schroder","year":"1987","unstructured":"Schroder H (1987) Methotrexate kinetics in myeloid bone marrow cells and peripheral neutrophils. Cancer Chemother Pharmacol 19(1):42\u201346","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"6162_CR46","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0026-895X(25)09028-5","volume":"42","author":"J Barredo","year":"1992","unstructured":"Barredo J, Moran RG (1992) Determinants of antifolate cytotoxicity: folylpolyglutamate synthetase activity during cellular proliferation and development. Mol Pharmacol 42(4):687\u2013694","journal-title":"Mol Pharmacol"},{"issue":"7508","key":"6162_CR47","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nature13323","volume":"511","author":"A Bessede","year":"2014","unstructured":"Bessede A, Gargaro M, Pallotta MT, Matino D, Servillo G, Brunacci C et al (2014) Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature 511(7508):184\u2013190","journal-title":"Nature"},{"issue":"1-2","key":"6162_CR48","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.taap.2010.04.020","volume":"246","author":"S Halwachs","year":"2010","unstructured":"Halwachs S, Lakoma C, Gebhardt R, Schafer I, Seibel P, Honscha W (2010) Dioxin mediates downregulation of the reduced folate carrier transport activity via the arylhydrocarbon receptor signalling pathway. Toxicol Appl Pharmacol 246(1\u20132):100\u2013106","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"6162_CR49","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1124\/mol.110.065078","volume":"78","author":"KP Tan","year":"2010","unstructured":"Tan KP, Wang B, Yang M, Boutros PC, Macaulay J, Xu H et al (2010) Aryl hydrocarbon receptor is a transcriptional activator of the human breast cancer resistance protein (BCRP\/ABCG2). Mol Pharmacol 78(2):175\u2013185","journal-title":"Mol Pharmacol"},{"issue":"3","key":"6162_CR50","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/art.24354","volume":"60","author":"JW van der Heijden","year":"2009","unstructured":"van der Heijden JW, Oerlemans R, Tak PP, Assaraf YG, Kraan MC, Scheffer GL et al (2009) Involvement of breast cancer resistance protein expression on rheumatoid arthritis synovial tissue macrophages in resistance to methotrexate and leflunomide. Arthritis Rheum 60(3):669\u2013677","journal-title":"Arthritis Rheum"},{"key":"6162_CR51","doi-asserted-by":"publisher","first-page":"867260","DOI":"10.3389\/fimmu.2022.867260","volume":"13","author":"M Cutolo","year":"2022","unstructured":"Cutolo M, Campitiello R, Gotelli E, Soldano S (2022) The role of M1\/M2 macrophage polarization in rheumatoid arthritis synovitis. Front Immunol 13:867260","journal-title":"Front Immunol"},{"issue":"6","key":"6162_CR52","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1161\/ATVBAHA.114.304650","volume":"35","author":"G Thomas","year":"2015","unstructured":"Thomas G, Tacke R, Hedrick CC, Hanna RN (2015) Nonclassical patrolling monocyte function in the vasculature. Arterioscler Thromb Vasc Biol 35(6):1306\u20131316","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"6162_CR53","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1136\/ard.2006.054056","volume":"66","author":"T Ellingsen","year":"2007","unstructured":"Ellingsen T, Hornung N, Moller BK, Poulsen JH, Stengaard-Pedersen K (2007) Differential effect of methotrexate on the increased CCR2 density on circulating CD4 T lymphocytes and monocytes in active chronic rheumatoid arthritis, with a down regulation only on monocytes in responders. Ann Rheum Dis 66(2):151\u2013157","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"6162_CR54","doi-asserted-by":"publisher","first-page":"385","DOI":"10.55563\/clinexprheumatol\/u1mi30","volume":"39","author":"DS Gibson","year":"2021","unstructured":"Gibson DS, McGeough CM, Watterson S, Blayney J, Wright GD, Pendleton A et al (2021) Anti-tumour necrosis factor-alpha response associated with combined CD226 and HLA-DRB1[*]0404 haplotype in rheumatoid arthritis. Clin Exp Rheumatol 39(2):385\u2013392","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"6162_CR55","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00296-011-1796-z","volume":"32","author":"Y Du","year":"2012","unstructured":"Du Y, Shen LX, Yu LK, Song Y, Zhu JF, Du R (2012) The CD226 gene in susceptibility of rheumatoid arthritis in the Chinese Han population. Rheumatol Int 32(5):1299\u20131304","journal-title":"Rheumatol Int"},{"key":"6162_CR56","doi-asserted-by":"publisher","first-page":"6881","DOI":"10.1038\/ncomms7881","volume":"6","author":"S Sharma","year":"2015","unstructured":"Sharma S, Patnaik SK, Taggart RT, Kannisto ED, Enriquez SM, Gollnick P et al (2015) APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophages. Nat Commun 6:6881","journal-title":"Nat Commun"},{"issue":"12","key":"6162_CR57","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1136\/ard.54.12.944","volume":"54","author":"P Emery","year":"1995","unstructured":"Emery P, Salmon M (1995) Early rheumatoid arthritis: time to aim for remission? Ann Rheum Dis 54(12):944\u2013947","journal-title":"Ann Rheum Dis"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-026-06162-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06162-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06162-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:15:12Z","timestamp":1781640912000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-026-06162-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6162"],"URL":"https:\/\/doi.org\/10.1007\/s00018-026-06162-9","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"19 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, was approved by the AEMPS (August 05th 2019) and the Ethical Committee of Hospital Universitario La Princesa and Hospital General Universitario Gregorio Mara\u00f1\u00f3n (protocol code: METOMAC-PAC, IGA-MET-2019\u201301).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"IC reports consulting and\/or speaker fees from Alfasigma, Boehringer, BMS, Eli-Lilly, Galapagos, Gebro Pharma, Gilead, GSK, Pfizer, UCB, not related to the submitted work. IGA reports personal fees from Lilly and Sanofi; personal fees and nonfinancial support from BMS; personal fees and non-financial support from Abbvie; research support, personal fees and non- financial support from Roche Laboratories; research support from Gebro Pharma; non-financial support from MSD, Pfizer and Novartis, not related to the submitted work. The other co-authors declare no potential conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"178"}}